Intrinsiqq

Medartis Holding AG (MED.XSWX) Quality Score

MED.XSWX
Quality57

Business quality is the primary weakness (avg 30/100). Growth is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
40/100
129.4x

Above 30x, priced for sustained outperformance

Cash Flow Multiple
40/100
115.2x

Above 30x, cash flow yield is thin

Revenue Growth
100/100
13.8%

Above 10% CAGR, strong compounder

Cash Flow Growth
100/100
182.3%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
30/100
4.9%

Diluting 2–5%, watch for SBC

Margin Trend
90/100
+1.7pp

Expanded 1–3pp, steady progress

Capital Structure
0/100
CHF 125M

Net debt/FCF of 13.4x, high leverage

2022
CHF 21M
CHF 27M
2023
CHF 25M
CHF 27M
2024
CHF 139M
CHF 121M
2025
CHF 33M
CHF 158M
Return on Capital
0/100
0.3%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Medartis Holding (MED.XSWX) quality: score, margins and returns

Medartis Holding (MED.XSWX) scores 57/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 8 metrics each scored 0 to 100, on 0.7% operating margins and 0.3% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Medartis Holding (MED.XSWX) a high-quality business?+

Medartis Holding scores 57 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a 0.7% operating margin and a 0.3% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Medartis Holding's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from MED.XSWX's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Medartis Holding scores well and where it falls behind.

What is Medartis Holding's return on invested capital (ROIC)?+

Medartis Holding earns about 0.3% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to MED.XSWX's margins and growth on this scorecard to judge durability.

How profitable is Medartis Holding?+

Medartis Holding runs an operating margin of about 0.7% and a net margin of about 3.5%. Revenue has grown at roughly 13.9% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Related stocks: Medical Devices

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.